Skip to main content
. 2022 Nov 3;36(6):2844–2851. doi: 10.21873/invivo.13024

Table V. Treatment after first-line chemotherapy finished.

graphic file with name in_vivo-36-2848-i0001.jpg

GnP: Gemcitabine with nab-paclitaxel; mFFX: modified FOLFIRINOX; PS: performance status. *1 case was modified FOLFOX and 1 case was 5-fluorouracil with leucovorin. Chemotherapy with multiple agents or chemoradiation.